1-cyclopentyl-4-methyl-1H-pyrazol-5-amine, 95.0%, 10g

2-Bromo-N-isopropylacetamide, 95.0%, 25g

1-((2-Butoxyethyl)sulfonyl)-4-methylbenzene, 95%, 5g

5-((tert-Butyldimethylsilyl)oxy)-3-iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole, 98%, 1g

1,4-Bis(acryloyloxy)butane (stabilized with MEHQ)>90.0%(GC)100g

8-Hydroxyquinoline-N-oxide, 97.0%, 5g

2-Amino-6-tert-butyl-4,5,6,7-tetrahydrobenzo[b]-thiophene-3-carboxylic acid methyl ester, 98.0%, 100g

Ethyl 2-ethyl-4-methyl-3-oxopentanoate, 95%, 500mg

Methyl 3-methoxypyridine-4-carboxylate, 95+%, 5g

2-Bromofluorobenzene>99.0%(GC)500g

(1R)-1-(6-METHOXY(3-PYRIDYL))PROPYLAMINE HCL, 95.0%, 250mg

6,7-Dihydro-1H-indazol-4(5H)-one, 95.0%, 1g

Silver sulphide, min. 98%, 10 g, glass packaging